Macquarie Group LTD Blueprint Medicines Corp Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

A detailed history of Macquarie Group LTD transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Macquarie Group LTD holds 1,263,661 shares of BPMC stock, worth $120 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

1,263,661

Previous 1,312,067 3.69%

Holding current value

$120 Million

Previous $141 Million 17.38%

% of portfolio

0.13%

Previous 0.17%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$84.1 - $120.5 $4.07 Million - $5.83 Million	-48,406 Reduced 3.69%	1,263,661 $117 Million
Q2 2024 Aug 09, 2024	BUY	$85.18 - $108.78 $70,614 - $90,178	829 Added 0.06%	1,312,067 $141 Million
Q1 2024 May 14, 2024	SELL	$73.17 - $99.79 $18.9 Million - $25.7 Million	-257,709 Reduced 16.43%	1,311,238 $124 Million
Q4 2023 Feb 14, 2024	SELL	$43.96 - $92.84 $478,944 - $1.01 Million	-10,895 Reduced 0.69%	1,568,947 $145 Million
Q3 2023 Nov 14, 2023	BUY	$46.9 - $66.0 $2.9 Million - $4.08 Million	61,756 Added 4.07%	1,579,842 $79.3 Million
Q2 2023 Aug 14, 2023	BUY	$42.2 - $66.37 $873,540 - $1.37 Million	20,700 Added 1.38%	1,518,086 $95.9 Million
Q1 2023 May 15, 2023	BUY	$37.97 - $50.0 $7.09 Million - $9.33 Million	186,636 Added 14.24%	1,497,386 $67.4 Million
Q4 2022 Feb 21, 2023	BUY	$41.06 - $66.48 $992,050 - $1.61 Million	24,161 Added 1.88%	1,310,750 $57.4 Million
Q3 2022 Nov 14, 2022	BUY	$49.93 - $77.7 $584,181 - $909,090	11,700 Added 0.92%	1,286,589 $84.8 Million
Q2 2022 Aug 15, 2022	BUY	$45.23 - $70.15 $1.9 Million - $2.94 Million	41,961 Added 3.4%	1,274,889 $64.4 Million
Q1 2022 May 16, 2022	SELL	$54.1 - $110.08 $2.37 Million - $4.83 Million	-43,834 Reduced 3.43%	1,232,928 $78.8 Million
Q4 2021 Feb 11, 2022	SELL	$94.25 - $115.99 $1.76 Million - $2.16 Million	-18,656 Reduced 1.44%	1,276,762 $137 Million
Q3 2021 Nov 12, 2021	BUY	$80.98 - $109.47 $10.9 Million - $14.8 Million	134,967 Added 11.63%	1,295,418 $133 Million
Q2 2021 Aug 13, 2021	BUY	$82.78 - $101.0 $26.4 Million - $32.2 Million	318,833 Added 37.88%	1,160,451 $102 Million
Q1 2021 May 14, 2021	BUY	$90.71 - $108.28 $672,614 - $802,896	7,415 Added 0.89%	841,618 $81.8 Million
Q4 2020 Feb 16, 2021	BUY	$92.08 - $124.48 $6.78 Million - $9.17 Million	73,638 Added 9.68%	834,203 $93.6 Million
Q3 2020 Nov 13, 2020	BUY	$66.45 - $92.7 $37.4 Million - $52.2 Million	563,027 Added 285.02%	760,565 $70.5 Million
Q2 2020 Aug 11, 2020	BUY	$57.09 - $79.27 $9.67 Million - $13.4 Million	169,374 Added 601.38%	197,538 $15.4 Million
Q1 2020 May 15, 2020	BUY	$48.11 - $82.22 $753,691 - $1.29 Million	15,666 Added 125.35%	28,164 $1.65 Million
Q4 2019 Feb 14, 2020	SELL	$66.73 - $82.59 $7.01 Million - $8.68 Million	-105,060 Reduced 89.37%	12,498 $1 Million
Q3 2019 Nov 14, 2019	BUY	$72.9 - $101.41 $8.57 Million - $11.9 Million	117,558 New	117,558 $8.64 Million

Others Institutions Holding BPMC

# of Institutions

350

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.65B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Blueprint Medicines Corp Transaction History